Adagio Therapeutics Announces New In Vitro Data Highlighting Broad and Potent Neutralization of ADG20 Against All Known SARS-CoV-2 Variants

NEXT STORY
Walmart to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Screening Test
PREV STORY
Opthea Opens Patient Enrollment in the Asia-Pacific Region for the OPT-302 ShORe and COAST Phase 3 Trials in Wet AMD
Subscribe to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cue Biopharma to Present at the Cowen 41st Annual Health Care Conference

author_avatar
NASDAQ Market News

China In-Vitro Diagnostics (IVD) Market 2007-2017 & 2018-2024: Cost Factor Restricts the Contribution of Global IVD Companies in the Chinese IVD Market

Dublin, Jan. 07, 2019 (GLOBE NEWSWIRE) -- The "China In-Vitro Diagnostics (IVD) Market, By ...

author_avatar
NASDAQ Market News

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

author_avatar
NASDAQ Market News